SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-19-038201
Filing Date
2019-02-13
Accepted
2019-02-13 17:00:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d679425dsc13g.htm SC 13G 35301
  Complete submission text file 0001193125-19-038201.txt   36678
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90685 | Film No.: 19598397
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 811 STRADA VECCHIA LOS ANGELES CA 90077
Business Address 811 STRADA VECCHIA LOS ANGELES CA 90077 650-457-2700
Seaview Trust (Filed by) CIK: 0001767779 (see all company filings)

IRS No.: 000000000
Type: SC 13G